Literature DB >> 32019335

Resolution of optic disc pit-associated macular retinoschisis after topical carbonic anhydrase inhibitor treatment: Report of a case.

Ahmad Al-Moujahed1, Natalia F Callaway1, Daniel Vail1, Cassie A Ludwig1, Marco H Ji1, Darius M Moshfeghi1.   

Abstract

BACKGROUND: Optic disc pits frequently lead to visual deterioration due to macular retinoschisis or serous retinal detachment. Here, we report a case of optic disc pit-associated macular retinoschisis due to intraretinal fluid accumulation that resolved with improvement in visual acuity after treatment with topical dorzolamide. CASE DESCRIPTION: A 56-year-old otherwise healthy female with no ocular history presented with 2 weeks of slowly worsening blurry vision in her right eye. Visual acuity was 20/30 in the right eye. Posterior segment examination revealed posterior vitreous detachment, an optic disc pit at 9 o'clock, macular edema and foveoschisis with fluid extending from the optic nerve, and a normal peripheral retina. Optical coherence tomography imaging of the macula showed central subfield thickness of 526 µm. The patient preferred no surgical intervention, so topical dorzolamide 2% three times daily was initiated. Over the next 2 years, the central subfield thickness steadily declined from 526 to 262 µm, and her vision improved to 20/20 with improvement in the macular retinoschisis.
CONCLUSION: Our report presents a case of resolution of optic disc pit-associated macular retinoschisis due to intraretinal fluid accumulation with possible role for dorzolamide as a potential treatment option.

Entities:  

Keywords:  Optic disc pit; carbonic anhydrase inhibitors; macular fluid; macular retinoschisis; topical dorzolamide (Trusopt)

Mesh:

Substances:

Year:  2020        PMID: 32019335     DOI: 10.1177/1120672120904664

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  1 in total

1.  Optic Pit Maculopathy: Adjunctive Treatment Using Oral Spironolactone and Topical Dorzolamide.

Authors:  Susan Ruyu Qi; Eunice You; Melanie Hebert; Ali Dirani
Journal:  Int Med Case Rep J       Date:  2021-05-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.